ScoreComparison
Why is Wuxi Biologics (Cayman), Inc. ?
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 47.82
2
Healthy long term growth as Net Sales has grown by an annual rate of 35.21% and Operating profit at 41.97%
3
Positive results in Dec 25
- OPERATING CASH FLOW(Y) Highest at HKD 12,995.95 MM
- INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
- ROCE(HY) Highest at 10.97%
4
With ROE of 10.12%, it has a Fair valuation with a 3.03 Price to Book Value
- Over the past year, while the stock has generated a return of 36.05%, its profits have risen by 53.3% ; the PEG ratio of the company is 0.5
5
Market Beating Performance
- The stock has generated a return of 36.05% in the last 1 year, much higher than market (Hang Seng Hong Kong) returns of 8.76%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Wuxi Biologics (Cayman), Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Wuxi Biologics (Cayman), Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Wuxi Biologics (Cayman), Inc.
36.05%
4.13
45.37%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
35.21%
EBIT Growth (5y)
41.97%
EBIT to Interest (avg)
47.82
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.38
Tax Ratio
18.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
13.03%
ROE (avg)
9.46%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
3.03
EV to EBIT
23.47
EV to EBITDA
17.84
EV to Capital Employed
3.57
EV to Sales
6.42
PEG Ratio
0.51
Dividend Yield
NA
ROCE (Latest)
15.21%
ROE (Latest)
10.12%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend19What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD 12,995.95 MM
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
ROCE(HY)
Highest at 10.97%
RAW MATERIAL COST(Y)
Fallen by -28.08% (YoY
CASH AND EQV(HY)
Highest at HKD 17,528.16 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -26.74 %
INVENTORY TURNOVER RATIO(HY)
Highest at 7.83 times
NET SALES(Q)
Highest at HKD 12,958.5 MM
OPERATING PROFIT(Q)
Highest at HKD 5,264.18 MM
OPERATING PROFIT MARGIN(Q)
Highest at 40.62 %
PRE-TAX PROFIT(Q)
Highest at HKD 3,735.36 MM
NET PROFIT(Q)
Highest at HKD 2,383.89 MM
EPS(Q)
Highest at HKD 0.67
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Wuxi Biologics (Cayman), Inc.
Operating Cash Flow
Highest at HKD 12,995.95 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Net Sales
Highest at HKD 12,958.5 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Operating Profit
Highest at HKD 5,264.18 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (HKD MM)
Operating Profit Margin
Highest at 40.62 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at HKD 3,735.36 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
Highest at HKD 2,383.89 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
EPS
Highest at HKD 0.67
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Cash and Eqv
Highest at HKD 17,528.16 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -26.74 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 7.83 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -28.08% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at HKD 970.25 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
